In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NanoMed Pharmaceuticals Inc.

Latest From NanoMed Pharmaceuticals Inc.

NanoMed Pharmaceuticals Inc.

The idea of delivering drugs encased in lipids was a popular one in the early days of the biotechnology industry but manufacturing problems pushed lipid-based drug delivery from favor. NanoMed Pharmaceuticals thinks it has found a way to get lipids to fulfill their potential as delivery vehicles, shielding the drugs they contain from cellular mechanisms responsible for drug resistance. The start-up aims to leverage its know-how to treat cancers notoriously resistant to chemotherapy.


Start-Up Previews (6/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Devices for Varicose Veins, features profiles of Vascular Insights, VeinRx and Venousonics. Plus these Start-Up Across Health Care: NanoMed Pharmaceuticals, Peakadilly, Quincy Bioscience and Solidus Biosciences.

See All

Company Information

  • Industry
  • Pharmaceuticals